In order to determine the staging of urinary bladder tumors accurately, it is very important to choose a suitable method of treatment and to reach the correct prognosis. In 1974, Watanabe and Holm performed the first transurethral and transrectal ultrasonography. They obtained sonograms of the involved bladder wall by radial scanning using a rotation transducer. The only weak point of this method is the difficulty of staging tumors in the apex, the neck, and the fundus of the bladder by transverse scanning. In 1982, Sekine et al repeated the results of testing a new transrectal transducer for electronic linear scanning in a urologic clinic. However, to our knowledge, no description of the transvaginal technique for routine vesical ultrasonography has appeared in the English-written literature. The purpose of this study is to visualize bladder tumors by longitudinal transvaginal scanning and to evaluate the new method for the staging of urinary bladder tumors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7863/jum.1988.7.4.179 | DOI Listing |
Cells
December 2024
Department of Mechanical Engineering, Tufts University, Medford, MA 02155, USA.
The development of noninvasive methods for bladder cancer identification remains a critical clinical need. Recent studies have shown that atomic force microscopy (AFM), combined with pattern recognition machine learning, can detect bladder cancer by analyzing cells extracted from urine. However, these promising findings were limited by a relatively small patient cohort, resulting in modest statistical significance.
View Article and Find Full Text PDFInvestig Clin Urol
January 2025
Department of Urology, Ewha Womans University College of Medicine, Seoul, Korea.
Purpose: Although the mechanism underlying interstitial cystitis/bladder pain syndrome (IC/BPS) remains unclear, oxidative stress is suggested to be implicated in IC/BPS development. Sea buckthorn (SB; L.) contains several compounds with antioxidant properties.
View Article and Find Full Text PDFInvestig Clin Urol
January 2025
Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Purpose: Mirabegron, the first-in-class beta-3 agonist, is the mainstay medication for overactive bladder (OAB). The aim of this study was to investigate the efficacy and safety of generic drugs of mirabegron (Mirabek) in adults diagnosed with OAB through a multicenter, prospective, non-interventional observational study.
Materials And Methods: Adult patients with OAB prescribed Mirabek SR Tab.
PeerJ
January 2025
Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Background: Plasma membrane tension-related genes (MTRGs) are known to play a crucial role in tumor progression by influencing cell migration and adhesion. However, their specific mechanisms in bladder cancer (BLCA) remain unclear.
Methods: Transcriptomic, clinical and mutation data from BLCA patients were collected from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases.
Low Urin Tract Symptoms
January 2025
Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Aim: This study aimed to analyze the clinical efficacy and safety of autologous fascial pubovaginal sling (AFPVS) surgery in treating recurrent stress urinary incontinence (SUI) following the failure of mid-urethral sling procedures.
Methods: A retrospective analysis was conducted on the clinical data of SUI patients who underwent AFPVS at our hospital between 2008 June and 2024 June following the failure of mid-urethral sling procedures. The analysis included basic information, surgical parameters, and postoperative complications.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!